The potential lack of response to treatment and alternative treatment (MTA
apexification, no treatment or extraction).
Mineral trioxide aggregate (MTA) has been widely indicated for several applications in Endodontics, among which sealing of perforations, pulp capping, pulpotomy,
apexification and use as a retrofilling material.
The treatment options for 37 were partial pulpotomy, cervical pulpotomy, pulpectomy and
apexification therapy or extraction.
Historically, acceptable long-term results are obtained through
apexification procedures using calcium hydroxide [1,2].
MTA has been a very commonly used material for retro-sealing, perforation repair and
apexification, being considered one of the most biocompatible materials that can be used with substantial certainty as to its biological behavior.
MTA has been utilized for many endodontic procedure including pulpotomy, pulp capping, perforation repair,
apexification, (4) and revascularization procedures (5).
Until now, the standard of care has entailed a procedure called
apexification that encourages root development, but doesn't replace the lost tissue and, even in a best-case scenario, causes root development to proceed abnormally.
LDF usage may thus be suitable to reach an early decision on whether treatment like
apexification and regenerative endodontic procedures after luxation injuries is needed.
The sealing ability and retention characteristics of mineral trioxide aggregate in a model of
apexification. J Endod 2002; 28(5):386-90.
Different materials have been tried for
Apexification procedure, the most common are calcium hydroxide and mineral trioxide aggregate (MTA).
Calcium silicate cements are bioactive materials used in various endodontic indications, such as pulp capping, pulpotomy, apexogenesis,
apexification, perforation repair, and root-end filling [1-4].